Literature DB >> 14627818

Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors.

Klaus Klumpp1, Julie Qi Hang, Surendran Rajendran, Yanli Yang, Andre Derosier, Philippe Wong Kai In, Hilary Overton, Kevin E B Parkes, Nick Cammack, Joseph A Martin.   

Abstract

Human immunodeficiency virus (HIV) RNase H activity is essential for the synthesis of viral DNA by HIV reverse transcriptase (HIV-RT). RNA cleavage by RNase H requires the presence of divalent metal ions, but the role of metal ions in the mechanism of RNA cleavage has not been resolved. We measured HIV RNase H activity associated with HIV-RT protein in the presence of different concentrations of either Mg2+, Mn2+, Co2+ or a combination of these divalent metal ions. Polymerase-independent HIV RNase H was similar to or more active with Mn2+ and Co2+ compared with Mg2+. Activation of RNase H by these metal ions followed sigmoidal dose-response curves suggesting cooperative metal ion binding. Titration of Mg2+-bound HIV RNase H with Mn2+ or Co2+ ions generated bell-shaped activity dose-response curves. Higher activity could be achieved through simultaneous binding of more than one divalent metal ion at intermediate Mn2+ and Co2+ concentrations, and complete replacement of Mg2+ occurred at higher Mn2+ or Co2+ concentrations. These results are consistent with a two-metal ion mechanism of RNA cleavage as previously suggested for a number of polymerase-associated nucleases. In contrast, the structurally highly homologous RNase HI from Escherichia coli is most strongly activated by Mg2+, is significantly inhibited by submillimolar concentrations of Mn2+ and most probably cleaves RNA via a one-metal ion mechanism. Based on this difference in active site structure, a series of small molecule N-hydroxyimides was identified with significant enzyme inhibitory potency and selectivity for HIV RNase H.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627818      PMCID: PMC290251          DOI: 10.1093/nar/gkg881

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase.

Authors:  J F Davies; Z Hostomska; Z Hostomsky; S R Jordan; D A Matthews
Journal:  Science       Date:  1991-04-05       Impact factor: 47.728

2.  Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid.

Authors:  Cathryn A Shaw-Reid; Vandna Munshi; Pia Graham; Abigail Wolfe; Marc Witmer; Renee Danzeisen; David B Olsen; Steven S Carroll; Mark Embrey; John S Wai; Michael D Miller; James L Cole; Daria J Hazuda
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

3.  Binding of metal ions to E. coli RNase HI observed by 1H-15N heteronuclear 2D NMR.

Authors:  Y Oda; H Nakamura; S Kanaya; M Ikehara
Journal:  J Biomol NMR       Date:  1991-09       Impact factor: 2.835

4.  Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.

Authors:  M Tisdale; T Schulze; B A Larder; K Moelling
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

5.  Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids.

Authors:  B M Wöhrl; K Moelling
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

6.  Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors.

Authors:  Kevin E B Parkes; Philipp Ermert; Jürg Fässler; Jane Ives; Joseph A Martin; John H Merrett; Daniel Obrecht; Glyn Williams; Klaus Klumpp
Journal:  J Med Chem       Date:  2003-03-27       Impact factor: 7.446

7.  Unified two-metal mechanism of RNA synthesis and degradation by RNA polymerase.

Authors:  Vasily Sosunov; Ekaterina Sosunova; Arkady Mustaev; Irina Bass; Vadim Nikiforov; Alex Goldfarb
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

8.  Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.

Authors:  V Gopalakrishnan; J A Peliska; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity.

Authors:  O Schatz; J Mous; S F Le Grice
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism.

Authors:  L S Beese; T A Steitz
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  65 in total

1.  Understanding the effect of magnesium ion concentration on the catalytic activity of ribonuclease H through computation: does a third metal binding site modulate endonuclease catalysis?

Authors:  Ming-Hsun Ho; Marco De Vivo; Matteo Dal Peraro; Michael L Klein
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

2.  Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.

Authors:  Catherine W Cai; Elena Lomonosova; Eileen A Moran; Xiaohong Cheng; Kunjan B Patel; Fabrice Bailly; Philippe Cotelle; Marvin J Meyers; John E Tavis
Journal:  Antiviral Res       Date:  2014-05-20       Impact factor: 5.970

Review 3.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

4.  Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.

Authors:  Joël Didierjean; Catherine Isel; Flore Querré; Jean-François Mouscadet; Anne-Marie Aubertin; Jean-Yves Valnot; Serge R Piettre; Roland Marquet
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.

Authors:  Lei Wang; Jing Tang; Andrew D Huber; Mary C Casey; Karen A Kirby; Daniel J Wilson; Jayakanth Kankanala; Jiashu Xie; Michael A Parniak; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2018-07-17       Impact factor: 6.514

6.  6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.

Authors:  Lei Wang; Jing Tang; Andrew D Huber; Mary C Casey; Karen A Kirby; Daniel J Wilson; Jayakanth Kankanala; Michael A Parniak; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2018-07-17       Impact factor: 6.514

7.  Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.

Authors:  Angela Corona; Francesco Saverio Di Leva; Sylvain Thierry; Luca Pescatori; Giuliana Cuzzucoli Crucitti; Frederic Subra; Olivier Delelis; Francesca Esposito; Giuseppe Rigogliuso; Roberta Costi; Sandro Cosconati; Ettore Novellino; Roberto Di Santo; Enzo Tramontano
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

8.  Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.

Authors:  Gaofeng Lu; Juan Antonio Villa; Maureen J Donlin; Tiffany C Edwards; Xiaohong Cheng; Richard F Heier; Marvin J Meyers; John E Tavis
Journal:  Antiviral Res       Date:  2016-09-28       Impact factor: 5.970

9.  Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site.

Authors:  Daniel M Himmel; Karen A Maegley; Tom A Pauly; Joseph D Bauman; Kalyan Das; Chhaya Dharia; Arthur D Clark; Kevin Ryan; Michael J Hickey; Robert A Love; Stephen H Hughes; Simon Bergqvist; Eddy Arnold
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

10.  Phosphodiester cleavage in ribonuclease H occurs via an associative two-metal-aided catalytic mechanism.

Authors:  Marco De Vivo; Matteo Dal Peraro; Michael L Klein
Journal:  J Am Chem Soc       Date:  2008-07-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.